1968•JAMARequires access

Rho (D) Immune Globulin (Human)

W. Q. Ascari

Abstract

RhO(D) immune globulin (RhoGAM) was administered to Rh negative women within 72 hours after they had given birth to Rh positive, ABO compatible infants to prevent Rh immunization. Two studies, differing only in the dose of anti-Rh immune globulin administered, have shown almost complete prevention of Rh immunization whereas in a group of Rh negative mothers who were not treated, and who were comparable by age, race, gravidity, and ABO blood group, the incidence of Rh immunization was 7%. This represents the first successful application of the concept of antibody-mediated immune suppression in humans to prevent disease.

About this research paper

What this paper is about

Why it matters

OpenAlex reports 18 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Key concepts: Medicine, ABO blood group system, Immunization, Immune system, Rh blood group system, Antibody, Immunology, Incidence (geometry)